{
    "root": "98f5bfec-4374-4cbc-b401-b0b1352858e4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Testosterone",
    "value": "20250312",
    "ingredients": [
        {
            "name": "TESTOSTERONE",
            "code": "3XMK78S47O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "OCTISALATE",
            "code": "4X49Y0596W"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        }
    ],
    "indications": "testosterone topical solution usp indicated replacement therapy males conditions associated deficiency absence endogenous testosterone : primary hypogonadism ( congenital acquired ) ( 1 ) hypogonadotropic hypogonadism ( congenital acquired ) ( 1 ) limitations : safety efficacy testosterone topical solution usp men `` age-related hypogonadism `` established . ( 1 ) safety efficacy testosterone topical solution usp males < 18 years old established ( 8.4 )",
    "contraindications": "prior initiating testosterone topical solution usp , confirm diagnosis hypogonadism ensuring serum testosterone concentrations measured morning least two separate days serum testosterone concentrations normal range .",
    "warningsAndPrecautions": "testosterone topical solution usp available metered-dose pump containing 110 ml solution . pump capable dispensing 90 ml solution 60 metered pump actuations . one actuation delivers 30 mg testosterone 1.5 ml solution . metered-dose pump supplied applicator . bottle applicator cup made natural rubber latex . ndc pump type 68180-943-11 pump actuated",
    "adverseReactions": "men carcinoma breast known suspected carcinoma prostate ( 4 , 5.1 ) pregnant breastfeeding women . testosterone may cause fetal harm ( 4 , 8.1 , 8.3 )",
    "indications_original": "Testosterone topical solution USP is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism      (congenital or acquired) ( 1 ) Hypogonadotropic hypogonadism      (congenital or acquired) ( 1 ) Limitations of use: Safety and efficacy of testosterone topical solution USP in men with \"age-related hypogonadism\" have not been established. ( 1 ) Safety and efficacy of testosterone topical solution USP in males <18 years old have not been established ( 8.4 )",
    "contraindications_original": "Prior to initiating testosterone topical solution USP, confirm the diagnosis of hypogonadism by ensuring that serum testosterone concentrations have been measured in the morning on at least two separate days and that these serum testosterone concentrations are below the normal range.",
    "warningsAndPrecautions_original": "Testosterone topical solution USP is available as a metered-dose pump containing 110 mL of solution. The pump is capable of dispensing 90 mL of solution in 60 metered pump actuations. One actuation delivers 30 mg of testosterone in 1.5 mL of solution. Each metered-dose pump is supplied with an applicator. The bottle and the applicator cup are not made with natural rubber latex. \n                        \n                           \n                           \n                           \n                              \n                                 \n                                    NDC\n                                    \n                                       \n                                    \n                                 \n                                 \n                                    Pump \n                                    Type\n                                    \n                                       \n                                    \n                                 \n                              \n                              \n                                 68180-943-11\n                                 \n                                 Pump Actuated",
    "adverseReactions_original": "Men with carcinoma of the      breast or known or suspected carcinoma of the prostate ( 4 , 5.1 ) Pregnant or breastfeeding      women. Testosterone may cause fetal harm ( 4 , 8.1 , 8.3 )"
}